Abstracts

Abstracts

Hamad,O.A., Ekdahl,K.N., Lambris,J.D. and Nilsson,B. (2007). Complement activation triggered by thrombin receptor-activated platelets. Molecular Immunology
Huber-Lang, M., Amara, U., Lambris, J. Ward, P.Gebhard, F. Bruckner, U. (2007). Cross talk of the coagulation and complement system. Inflammation Research
Janssen, B. J. C., Christodoulidou, A.Katragadda, M. Lambris, J. D. Gros, P. (2007). Structure of complement component C3b. Molecular Immunology 44(1-3):189.
Janssen, B. J. C., Halff, E., Lambris, J. D. Gros, P. (2007). Structure of C3c in complex with compstatin reveals a new mechanism of complement inhibition. Molecular Immunology 44(16):3930.  
Katragadda, M., Sfyroera, G., Paola, M.Janssen, B. J. C. Gros, P.and Lambris, J. D. (2007). Structure-activity-based design of potent compstatin analogs. Molecular Immunology 44(1-3):192.  
Lambris, J. D., Sfyoera, G., Hammel, M.Ricklin, D. Magotti, P. Geisbrecht, B. V. (2007). A novel complement evasion mechanism of Staphylococcus aureus using Efb. Molecular Immunology 44(16):3926.  
Lambris, J. D., Sfyroera, G., Schuster, M. Chen, H.Tzekou, A.Papp, K.Winters, M. Woods, V. L. (2007). Studies on the solvent accessibility of native C3 and its fragments, as analyzed by HDX-MS. Molecular Immunology 44(1-3):202.  
Markiewski, M. M., DeAngelis, R. A.Foukas, P. G. Lambris, J. D. (2007). Complement - A regulator of pro-survival pathways in liver regeneration. Molecular Immunology 44(1-3): 213-214.  
Ricklin, D. Sfyoera, G., Hammel, M.Magotti, P. Geisbrecht, B. V. Lambris, J. D . (2007). Combining Forces against Bacterial Infections - Using SPR, ITC, Biochemical and Structural Data to Describe a Novel Complement Evasion Mechanism of Staphylococcus Aureus. DIPIA  
Ricklin, D. Sfyoera, G., Hammel, M.Magotti, P. Geisbrecht, B. V. Lambris, J. D. (2007). Molecular Interactions of Efb: Describing a Novel Complement Evasion Mechanism of Staphylococcus Aureus. 21st Annual Symposium of The Protein Society, Boston  
Ritis, K. Doumas, M.Mastellos, D. Micheli, A. Giaglis, S. Magotti, P. Farail, S.Kartalis, G. Sideras, P. Lambris, J. D. (2007). A novel C5aR-tissue factor crosstalk in neutrophils links innate immunity to coagulation pathways. Molecular Immunology 44(1-3):266.  
Sarma, V. Huber-Lang, M. Zetoune, F. S. Rittirsch, D. Lambris, J. D. Drouin, S. M. Wetsel, R. A. Ward, P. A. (2007). Generation of C5a in the absence of C3: A new complement activation pathway. Molecular Immunology 44(1-3):235.  
Sfyroera, G. Melillo, D. De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R. (2007). First identification of a chemotactic receptor in an invertebrate species: Structural and functional characterization of Ciona intestinalis C3a receptor. Molecular Immunology 44(1-3): 238-239.  
Sfyroera, G. Melillo, D. De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R. (2007). First identification of a chemotactic receptor in an invertebrate species: Structural and functional characterization of Ciona intestinalis C3a receptor. Molecular Immunology 44(1-3): 238-239.  
Thurman,J.M., Lenderink,A.M., Royer,P.A., Zhou,J., Lambris,J.D., Nemenoff,R.A., Quigg,R.J. and Holers,V.M. (2007). Activation of the alternative pathway of complement after renal ischemia/reperfusion induces the production of C-X-C chemokines. Molecular Immunology 44 (1-3):250.  
Tjernberg, J., Lindblom, S., Ekdahl, K. N. Lambris, J. Korsgren, O. Nilsson, B. (2007). Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Xenotransplantation 14(5):454.  
Waage, C. Nielsen, E. W. Fure, H.Brekke, O. L. Sfyoera, G. Lambris, J. D. Mollnes, T. E. (2007). Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement. Molecular Immunology 44(1-3):254.  
Zhang, X. H. Kimura, Y., Fang, C. Y. Zhou, L.Sfyroera, G. Lambris, J. D. Wetsel, R. A. Miwa, T.and Song, W. C. (2007). Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Molecular Immunology 44 (1-3):263.  
Archontis, G., Tarnamis, P., Skourtis, S. S. Morikis, D. Lambris, J. D. (2007). Conformational analysis of compstatin analogues with molecular dynamics simulations in explicit water. Molecular Immunology 44(1-3):150.
Engberg, A. E., Lambris, J. D., Nilsson, B. Nilsson-Ekdahl, K. (2006). Mass Spectrometric indentification of proteins that binding to biomaterial surfaces. Evidence for covalent binding of C3 to surfcae bound proteins. 4rth, International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:85.  
Hamad, A. Lambris, J. D. Nilsson-Ekdahl, K. Nilsson, B. (2006). Complement activation induced by thrombin receptor-activated platelets. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:87.  
Lambris, J. D. (2006). Protein-protein interactions in the complement system and development of compement therapeutics. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:60.  
Markiewski, M. M., DeAngelis, R. A.Foukas, P. G. Lambris, J. D. (2006). Complement - a regulator of pro-survival pathways in liver regeneration. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:37.  
Melillo, D. Sfyoera, G., De Santis, R. Graziano, R. Marino, R.Lambris, J. D. Pinto, M. R. (2006). First indentification of a chemotactic receptor in an invertebrate species: structural and functional characterization of Ciona intestinalis C3a receptor. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:41.  
Stevens, B. Christopherson, K. S. Huberman, A. D. Lambris, J. D. Barres, B. A. (2006). The complement cascade mediates developmental synapse elimination. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:38.  
Thurman, J. M., Lenderink, A. M.Royer, P. A. Zhou, J.Lambris, J. D. Nemenoff, R. A. Quigg, R. J. Holers, M. (2006). Activation of the alternative pathway of complement after renal ischemia/reperfusion induces the production of C-X-C chemokines. XXI ICW.Beijing, China, Molucular Immunology 44(1-3):250.  
Zetoune, F. S., Huberman, A. D.Sarma, V.Rittirsch, D. Lambris, J. D. Ward, P. (2006). C5a gemeration in the absence of C3. 4rth International Innate Immunity Conference, Corfu, Greece, Aegean Conferences 23:43.  
Zetoune,F.S., Sarma,J.V., Rittirsch,D., Lambris,J.D., McGuire,S.R. and Ward,P.A. (2006). Thrombin as a C5 convertase. Faseb Journal 20(4):A641.  
Bergseth,G., Lappegard,K.T., Lambris,J.D., Fure,H. and Mollnes,T.E. (2006). Complement-dependent chemokine synthesis induced by an artificial surface: role of leukocyte subpopulations. Molecular Immunology 43(1-2):171-172.  
Lambris, J. D. (2006). A "multidisciplinary" approach to understand disease pathogenesis and develp therapeutics. 4rth International Conference on Pathways, Networks and Systems: Theory and Experiments, Mykonos, Greece, Aegean Conferences 27:44.  
Kohl, J. Balder, R.Lewkowich, I. Pandey, M. K Hawlisch, H. Wang, L.Herman, N.Sproles, A. Best, J.Zwirner, J. Whitsett, J. D. Lambris, J. D. Wills-Karp, M. (2005). A regulatory role for the C5a anaphylatoxin on type 2 immunity in asthma. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:35.  
Kohl, J. Balder, R.Lewkowich, I. Pandey, M. K Hawlisch, H. Wang, L.Herman, N.Sproles, A. Best, J.Zwirner, J. Whitsett, J. D. Lambris, J. D. Wills-Karp, M. (2005). A regulatory role for the C5a anaphylatoxin on type 2 immunity in experimental asthma. 10th European Meeting on Complement in Human DiseaseHeidelberg, Germany  
Lambris, J. D. (2005). Intergrating innate immunity into a "systems context"; the complement paradigm. Crossroads between innate and Adaptive Immunity. Rhodes, Greece, Aegean Conferences 21:30.  
Lambris, J. D. (2005). Intergrating innate immunity into a "systems context"; the complement paradigm. 3rd International Conference on Pathways, Networks and Systems: Theory and Experiments. Rhodes, Greece, Aegean Conferences2 0:28.  
Lambris, J. D. (2005). A "multidisciplinary" approach to today's challenges in biosciences. 13th Signal and Signal Processing in the Immune System.EFIS ConferenceBalatonoszod, Hungary, September  
Lambris, J. D. (2005). From atoms to systems: A "multidisciplinary approach to today's challenges in biosciences. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:34.  
Lambris, J. D. (2005). A "multidisciplinary" approach to today's challenges in biosciences. 2nd International Conference on Tissue Enginnering, Crete, Greece, Aegean Conferences 16:88.  
Lambris, J. D. (2005). A "multidisciplinary" approach to today's challenges in biosciences. 3rd Workshop on Lymphocyte Signal Transduction, Crete, Greece, Aegean Conferences 17:63.  
Madhavan, M. C., Tsonis, P. A., Lambris, J. D. Del Rio-Tsonis, K. (2005). A role of complement components in regeneration. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:24.  
Mocco, J. Mack, W. J. Botto, M.Holland, M. C. H. Lambris, J. D. Pinsky, D. J. Connolly, E. S. (2005). Aggressive reduction of C3 is critical to alleviating complement mediated injury following cerebral ischemia/reperfusion. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:29.  
Reca, R. Lambris, J. D., Ross, G. D. Ratajczak, M. (2005). Transplantation studies in C3-deficient animals reveal a novel role of third complement component(C3) in engrament/regeneration of bone marrow. 3rd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Rhodes, Greece, Aegean Conferences 18:25.  
Fabry, Z. Nacewicz, B. Liu, F.Sewell, D.Macvilay, S. Erdei, A.Lambris, J. D. Sandor, M. (2004). Role of complement in acute traumatic brain injury. Molecular Immunology 41(2-3):227.  
Lambris, J. D. (2004). From Atoms to Systems: A "Multidisciplinary" Approach to Innate Immunity. 3rd International Conference on Innate Immunity, Mykonos, Greece, Aegean Conferences 13:63.  
Lambris, J. D., Katragadda, M., Spruce, L.and Morikis, D. (2004). The compstatin case: an UPDATE, on its structure and functions. Molecular Immunology 41(2-3):265.  
Mallik,B., Lambris,J.D. and Morikis,D. (2004). Rational design of a potent inhibitor for unregulated complement activation using molecular dynamics simulations and nuclear magnetic resonance data. Abstracts of Papers of the American Chemical Society 227:U908-U909.  
Markiewski, M. M., Mastellos, D., Tudoran, R. Strey, C. W. DeAngelis, R. A. Franchini, S. Wetsel, R. A. Erdei, A.and Lambris, J. D. (2004). The role of complement in liver regeneration: both C3a and are critical for normal liver recovery after toxic injury. Molecular Immunology 41(2-3):273.  
Morikis, D. Mallik, B.and Lambris, J. D. (2004). NMR and molecular simulations as tools for characterization of compastatin and active hybrid peptide-peptidomimetic analogs. Molecular Immunology 41:281-282.  
Morikis,D. and Lambris,J.D. (2004). Electrostatics drive C3D-CR2 association. Abstracts of Papers of the American Chemical Society 227:U913.  
Sandor, M. Lambris, J. D. Suresh, M. (2004). Complement Regulates T Cell Responses. 3rd International Conference on Innate Immunity, Mykonos, Greece, Aegean Conferences 13:37.  
Sfyroera, G. Isaacs, S. N. Katragadda, M. Lambris, J. D. (2004). Structural-functional analysis of VCP and SPICE interactions with C3b. Molecular Immunology 41(2-3): 305-306.  
Winters,M.S., Spellman,D.S. and Lambris,J.D. (2004). Solvent accessibility of native and hydrolyzed human complement protein 3 analyzed by hydrogen/deuterium exchange and mass spectrometry. Protein Science 13 :102-103.  
Yamada, K. Miwa, T.Liu, J.Nangaku, M. Lambris, J. D. Song, W. C. (2004). Critical protection from renal ischemia reperfusion injury by DAF and CD59. Molecular Immunology 41(2-3): 328-329.  
Allendorf, D. J., Baran, J. T., Hansen, R. D. Subbarao, K. Walsh, D.Hong, F.Marroquin, J. Yan, J.Lambris, J. D. Haribabu, B. Ross, G. D. (2003). Orally administered beta-glucan functions via anti-tumor mAbs and the complement system to recruit CR3(+) neutrophils and macrophages that produce tumor regression and tumor-free survival. Molecular Immunology 40(2-4): 195-196.  
Blatteis, C. M., Li, S. X., ballou, L. R. Boackle, S. A. Holers, M.and Lambris, J. D. (2003). Complement and the pathogenesis of endotoxic fever. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:59.  
Girardi, G. Berman, J.Hollmann, T. Lambris, J. D. Wetsel, R. A. Holers, M.and Salmon, J. E. (2003). C5a-C5aR interactions and recruitment of PMN mediate antiphospholipid antibody(aPL)-induced pregnancy loss in mice. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:54.  
Girardi, G. Berman, J.Tudoran, R. Chinnici, C. Erdei, A.Lambris, J. Salmon, J. (2003). A potential mechanism for therapeutic efficacy for heparin in antiphospholipid-induced pregnancyloss-inhibition of complement. Arthritis and Rheumatism 48(9):S163.  
Lambris, J. D., Del Rio-Tsonis, K.Franchini, S. Kimura, Y.Markiewski, M. M. Mastellos, D. Strey, C. W. Tsonis, P. A. (2003). The role of complement in developmental processes. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:52.  
Li, S. X. Lambris, J. D. Blatteis, C. M. (2003). Complement(C) and lipopolysaccharide(LPS)-induced fever: C5a is essential. Faseb Journal 17(7):C108.  
Li, S. X. Lambris, J. D. Blatteis, C. M. (2003). Complement(C) and lipopolysaccharide(LPS)-induced fever: C5a is essential.. Faseb Journal 17(7):C108.  
Madhavan, M. C., Kimura, Y., Call, M. K. Santiago, W. Tsonis, P. A. Lambris, J. D. Del Rio-Tsonis, K. (2003). Do complement molecules play a role in lens regeneration?. Investigative Ophthalmology & Visual Science 44:U324.  
Morikis, D. Mallik, B.and Lambris, J. D. (2003). Molecular dynamics simulations of the NMR structural ensemble of Compstatin: A first step towards dynamics-activity relations in rational drug design. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:45.  
Morikis, D.and Lambris, J. D. (2003). Immunophysics of the complement system: The role of electrostatic fields in C3d-CR2(SCR1/SCR2) association. 2nd Workshop on Complement Associated Diseases, Animal Models and Therapeutics, Myconos, Greece, Aegean Conferences 9:44.  
Mullick, J. Bernet, J.Singh, A. K. Lambris, J. D. Sahu, A. (2003). Kaposi's sarcoma-associated herpesvirus open reading frame 4 protein(Kaposica) targets C3 and C4 to inactivate complement. Molecular Immunology 40(2-4):175.  
Ross, G. D. Hansen, R. D. Allendorf, D. J. Baran, J. T. Yan, J.Subbarao, K. Haribabu, B. Lambris, J. D. (2003). Tumor regression mediated by beta-glucans against iC3b-opsonized tumors requires CR3(+) neutrophils recruited via C5a and leukotriene B-4(LTB4). Faseb Journal 17(7):C128.  
Yamada, K. Miwa, T.Liu, J. N.Funk, C.Lambris, J. D. Nangaku, M. Song, W. C. (2003). Time-dependent involvement of complement and leukotriene pathways in a mouse model of renal ischemia reperfusion injury. Journal of the American Society of Nephrology 14:565A.  
Brekke, O. L., Fure, H. Christiansen, D.Lappegard, K. T. Fung, M.Lambris, J. D. Mollnes, T. E. (2002). Key role of the C5a receptor in Escherichia coli-induced oxidative burst and phagocytosis studied in a novel human whole blood model of inflammation. International Immunopharmacology 2:1235.  
Erdei, A. Laszlo, G.POlah, E.Prechi, J.Papp, K.Csomor, E.Argyropoulos, E. Franchini, S. Mastellos, D. Lambris, J. D. (2002). Monoclonal antibodies against mouse C3-fragments; A new repertoire of reagents targeting C3-mediated functions. International Immunopharmacology 2:1327.  
Fleming, S. D., Lambris, J. D., Shea-Donohue, T. Tsokos, G. C. (2002). The C5a fragment of C5 is critical for the mesenteric ischemia/reperfusion-induced local and remote organ injury. Int.Immunopharmacol 2(9):1308.  
Girardi, G. Berman, J.Spruce, L.Lambris, J. D. Holers, M.and Salmon, J. E. (2002). A critical role for complement C5 in antiphospholipid antibody-induced pregnancy loss. Arthritis and Rheumatism 46(9):S219.  
Girardi, G. Berman, J.Spruce, L.Lambris, J. D. Holers, M.and Salmon, J. E. (2002). Complement C5 activation mediates antiphospholipid antibody-induced pregnancy loss. Int.Immunopharmacol 1239.  
Kijowski, J. Reca, R.Majka, M.Mastellos, D. Janowska-Wieczorek, A. Lambris, J. Ratajczak, M. Z. (2002). Evidence that anaphylatoxin C3a cooperates with SDF-1 in homing/mobilization of hematopoietic stem/progenitors by priming CXCR4 responses to SDF-1. Blood 100(11):108A.  
Kimura, Y. Lambris, J. D. Tsonis, P. A. Del Rio-Tsonis, K. (2002). The role of compelement in newt lens and limb regeneration. International Immunopharmacology 2:1364.  
Lappegard, K. T., Hvassing, T., Fung, M.Lambris, J. D. Riesenfeld, J. Mollnes, T. E. (2002). Attenuation of artificial surface-induced leukocyte activation by blocking C2, factor D, C5 and C5a receptor. International Immunopharmacology 2:1308.  
Miwa, T. Zhou, L.Hilliard, B. Lambris, J. D. Molina, H.and Song, W. C. (2002). Differential roles of DAF, Crry and CD59 in regulating alternative and classical pathway complement activation on murine erythrocytes. International Immunopharmacology 2:1223.  
Morikis, D. Soulika, A. M Lambris, J. D. (2002). Rational design of a complement inhibitor targeting C3 using NMR and combinatorial approaches. Biochemical Society Transactions 30:A100.  
Morikis, D. Soulika, A. M Lambris, J. D. (2002). Structural-activity based design of compstatin using analogs NMR and combinatorial approaches. International Immunopharmacology 2:1229-1230.  
Nacewicz, B. Liu, F.Sewell, D.Lambris, J. D. Sandor, M.and Fabry, Z. (2002). The role of complement in traumatic injury of the brain. Faseb Journal 16(4):A682.  
Ratajczak, M. Z., Reca, R.Majka, M., Kijowski, J. Mastellos, D. (2002). The role of a newly identified heterologous crosstalk between G-protein coupled seven-transmembrane span receptors: Chemokine receptor CXCR4 and complement C3aR in human hemato-lymphopoiesis and innate immunity. International Immunopharmacology 2: 1351.  
Reca, R. Majka, M.Janowska-Wieczorek, A. Lambris, J. Ratajczak, M. (2002). A new unexpected role of the third complement component (C3a)-C3a receptor(C3aR) axis in regulating human hematopoiesis. Experimental Hematology 30(6):59.  
Reca, R. Majka, M.Mastellos, D. Janowska-Wieczorek, A. Lambris, J. D. Ratajczak, M. Z. (2002). Normal human CD34 hematopoietic progenitors, myeloblasts, megakaryoblasts and erythroblasts express functional complement C3a receptor that sensitizes their chemotactic responses to SDF-1. Blood 100(11):148B.  
Spruce, L. Argyropoulos, E. Mastellos, D. Sfyoera, G. Lambris, J. D. (2002). Chemical synthesis of small complement proteins and protein modules. International Immunopharmacology 2:1320-1321.  
Strey, C. W. Markiewski, M. M. Mastellos, D. Tudoran, R. Greenbaum, L. Lambris, J. (2002). The role of complement in liver regeneration. International Immunopharmacology 2:1249.  
Strey, C. W. Spellman, d Markiewski, M. M. Lambris, J. D. (2002). Proteomic analysis of mouse C3 deficiency and liver partial hepatectomy. International Immunopharmacology 2:1241.  
Wyss-Coray, T., Lin, A. H. T., Yan, F. R.Lambris, J. Alexander, J. J. Quigg, R. J. Masliah, E. (2002). Overproduction of complement inhibitor Crry increases Alzheimer's-type pathology in transgenic mice. Neurobiology of Aging 23: S221.  
Zetoune, F. S., Huber-Lang, M. S.Riedemann, N. C. Sarma, V.Neff, T.Younkin, E. M. Laudes, I. J. McGuire, S. R. Guo, R. F.Lambris, J. D. Spruce, L.Mastellos, D. Ward, P. A. (2002 ). Role for C5a in mouse peritoneal sepsis. Faseb Journal16 (4):A592.  
Christiansen, D., Fure, H.Bergseth, G., Lambris, J. D. Mollnes, T. E. (2001). E-coli-induced upregulation of granulocyte CR3 contributes to oxidative burst and is totally C5a receptor dependent. Molecular Immunology 38(2-3):83.  
Fabry, Z. Nazewicz, B. Liu, F.Sewell, D.Lambris, J. D. Sandor, M. (2001). The role of complement in acute traumatic injury of the brain. International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October  
Fleming, S. D., Lambris, J. D., Shea-Donohue, T. Tsokos, G. C. (2001). C5a in responsible for the mesenteric ischemia/reperfusion-induced local and remote organ injury. International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October  
Fure, H. Christiansen, D. Brekke, O. L. Bergseth, G. Lappegard, K. T. Lambris, J. D. Fung, M.and Mollnes, T. E. (2001). E-coli-induced oxidative burst is complement dependent and can be abolished by different modes of complement inhibition. Molecular Immunology 38(2-3): 90-91.  
Kijowski, J. Majka, M.Reca, R.Rozmyslowicz, T. Conover, D. O. Murphy, S. L. Janowska-Wieczorek, A. Gaulton, G. N. Lambris, J. Ratajczak, M. Z. (2001). The role of newly-identified heterologous crosstalk between G-protein coupled chemokine and complement seven transmembrane span receptors in human thymopoiesis. Blood 98(11):821A.  
Lambris, J. D., Del Rio-Tsonis, K.Franchini, S. Kimura, Y.Majka, M.Markiewski, M. M. Mastellos, D. Ratajczak, M. Z. Reca, R.Strey, C. W. Tsonis, P. A. (2001). The role of complement in developmental processes. International Workshop on Complement Associated Diseases, Santorini, Greece,October  
Lappegard, K. T., Bergseth, G., Lambris, J. D. Riesenfeld, J. Mollnes, T. E. (2001). Studies on the relationship between complement and leukocyte activation in blood circulated in uncoated and heparin coated PVC tubing. Molecular Immunology 38(2-3):105.  
Morikis, D. Soulika, A. M Roy, M.Troganis, A. Jennings, P. A. Tsokos, G.and Lambris, J. D. (2001). Rational design of a complement inhibitor targeting C3. International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October  
Reca, R. Majka, M.Mastellos, D. Zhao, D. L. Janowska-Wieczorek, A. Lambris, J. D. Ratajczak, M. Z. (2001). New unexpected stimulatory effects of complement proteins on human hematopoiesis: Evidence for crosstalk between G-protein-coupled C3a complement receptor(C3aR) and alpha-chemokine SDF-1 receptor(CXCR4). Blood 98(11):64A.  
Solvik, U. O., Haraldsen, G., Fiane, A. E. Boretti, E. Lambris, J. D. Fung, M.Thorsby, E. Mollnes, T. E. (2001). Human serum-induced E-selectin expression on porcine aortic endothelial cells is totally complement mediated: evidence for a role of complement in delayed xenograft rejection. Xenotransplantation 8:120.  
Ward, P. Huber-Lang, M. S. Reidemann, N. Spruce, L.Mastellos, D. Lambris, J. D. (2001). C5a in inflammatory responses: just right or too much?. International Workshop on Complement Associated Diseases, Animal Models and Therapeutics. Santorini, Greece, October  
Franchini, S., Zarkadis, I. K.Sfyroera, G. Sahu, A.and Lambris, J. D. (2000). Cloning and purification of the rainbow trout fifth component of complement(C5). Immunopharmacology 49:13.  
Friedman, H. M., Saldanha, C., Wang, L. Y. Jiang, M.Grippi, K.Lambris, J. D. Lubinski, J. (2000). Herpes simplex virus immune evasio. Clinical Infectious Diseases 31(1):316.  
Guthridge, J., Rakstang, J, Young, KHinshelwood, J. Sarrias, M. R. Moore, W. T. Perkins, S. J. Overduin, M. Lambris, J. D. Karp, D.Hannan, J.and Holers, M. (2000). CR2/CD21 SCR1,2 domain ligand binding, physical properties and structural analysis. Immunopharmacology 49: 46.  
Guthridge, J., Younf, K. , Gipson, M.Hinshelwood, J. Sarrias, M. R. Lambris, J. D. Perkins, S. J. Holers, M. (2000). Novel inhibitory monoclonal antibodies to human CR2/CD21 ligand binding domains. Immunopharmacology 49:69.  
Lambris, J. D., Sahu, A., Soulika, A. M, Morikis, D. Moore, W. T. Spruce, L.and Sarrias, M. R. (2000). Compstatin: Structure-activity relationship, biotransformation, in vivo studies, and therapeutic potential. Innate Immunity Workshop, Santorini, Greece  
Lambris, J. D., Zarkadis, I. K.Franchini, S. Kimura, Y.Sarrias, M. R. Sfyroera, G. Moore, W. T. Sahu, A. (2000). Evolution and diversity of the complement system. Innate Immunity Workshop, Santorini, Greece  
Lambris, J. D., Zarkadis, I. K.Sarrias, M. R. Franchini, S. Sfyroera, G. Sahu, A. (2000). Structure and fuctions of trout complement proteins. Dev.Comp. Immunology 24:23.  
Mastellos, D., papadimitriou, SFranchini, S. Tsonis, P. A. Lambris, J. D. (2000). A role of Complement component C5 in liver regeneration. Immunopharmacology 49:8.  
Mollnes, T. E., Brekke, O. L., Koehl, J.Bergseth, G. Christiansen, D. Fure, H.Lappegard, K. T. Videm, V.Sahu, A.and Lambris, J. D. (2000). Inhibition of endotoxin-induced oxidative burst by the C3 binding peptide compstatin in a novel whole blood model of inflammation. Immunopharmacology 49:62.  
Moore, W. T.and Lambris, J. D. (2000). Proteomic analysis of C3 and its fragments. Immunopharmacology 49:43.  
Sahu, A. Soulika, A. M Morikis, D. Spruce, L.Moore, W. T. Lambris, J. D. (2000). Kinetics and proposed mechanism of binding of the complement inhibitor Compstatin. Immunopharmacology 49:53.  
Song, W. C. Scalia, R.Miwa, T.Lambris, J. D. Lefer, A. M. (2000). Dificiency of decayaccelerating factor(DAF) attenuates leukocyte-endothelium interation induced by hemorrhage and reinfusion. Immunopharmacology 49:24.  
Soulika, A. M, Khan, T.Hattori, F. W, Bowen, B. A Richardson, C. E Hack, C. E. Sahu, A.Edmunds, L. H Lambris, J. D. (2000). Inhibition of heparin/protamine complex-induced complement activation by Compastatin in baboons. Immunopharmacology 49:62.  
Zarkadis, I. K., Sfyoera, G., Kimura, Y.Franchini, S. Sahu, A.Moore, W. T. Lambris, J. D. (2000). Characterization of a factor H like molecules in rainbow trout. Innate Immunity Workshop, Santorini, Greece  
Zarkadis, I. K., Sfyroera, G., Franchini, S. Sahu, A.and Lambris, J. D. (2000). Characterization of factor H-like molecules in rainbow trout. Dev.Comp.Immunol 24:13.  
Irani, V. R.and Lambris, J. D. (1999). Studies on the interaction of C3dg with CR2. Faseb Journal13 (4):A282.  
Lambris,J.D. and Volanakis,J.E. (1999). Special Issue - Papers presented at the XVIIth International Complement Workshop - Rhodes, Greece - 11-16 October 1998 - Preface. Immunopharmacology 42 (1-3):IX.  
Noorchashm, H., Moore, D. J., Lieu, Y. K., Noorchashm, N., Schlachterman, A., Song, H. K., Lambris, J. D., Barker, C. F., and Naji, A. (1999). Contribution of the innate immune system to autoimmune diabetes: A role for the CR1/CR2 complement receptors. Cellular Immunology 198(2):143.  
Friedman,H.M., Wang,L., Nagashunmugam,T., Lambris,J.D., Pangburn,M.K., Sahu,A., Soulika,A., Wetsel,R.A., Colten,H., Eisenberg,R.J., Cohen,G.H. and Lubinski,J. (1998). HSV-1 glycoprotein gC complement regulatory domains involved in virulence. Molecular Immunology 35 (6-7):348.  
Lambris,J.D. and Volanakis,J.E. (1998). Abstracts of the XVII international complement workshop - Preface. Molecular Immunology 35 (6-7):329.  
Mollnes,T.E., Fiane,A.E., Videm,V., Sahu,A., Hovig,T., Mellbye,O.J., Hogasen,J., Spruce,L., Moore,W. and Lambris,J.D. (1998). Attenuation of hyperacute xenograft rejection in a porcine-to-human ex vivo model by a peptide based C3 inhibitor. Molecular Immunology 35(6-7):372.  
Moore,W.T. and Lambris,J.D. (1998). Mass spectrometric analysis of the activation and expression products of the third component of complement (C3). Molecular Immunology 35(6-7):373.  
Mvones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D.(1998). Cofactor activity for C3 cleavage is preserved in complexes of complement factor H and phospholipids: Relationship to antiphospholipid antibodies. Arthritis and Rheumatism, 41(9):S172Mvones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D. (1998). Cofactor activity for C3 cleavage is preserved in complexes of complement factor H and phospholipids: Relationship to antiphospholipid antibodies. Arthritis and Rheumatism 41(9):S172.  
Myones,B.L., Antonov,I.V., Fedorova,L.I., Volgin,A.Y., Peterson,L.H. and Lambris,J.D. (1998). Complexes of factor H and phospholipids retain cofactor activity for C3 cleavage: Relationship to antiphospholipid antibodies. Molecular Immunology 35 (6-7):373.  
Nilsson, B., Larsson, R., Hong, J., Elgue, G., Ekdahl, K. N., Sahu, A., and Lambris, J. D. (1998). Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Molecular Immunology 35(6-7):371.  
Noorchashm,H., Lieu,Y.K., Wetsel,R., Colten,H.R., Barker,C.F., Soulika,A., Rostami,S.Y., Lambris,J.D. and Naji,A. (1998). B cell tolerance: A C3 dependent process. Molecular Immunology 35(6-7):371.  
Sahu, A., Isaacs, S. N., Soulika, A. M., and Lambris, J. D. (1998). Interaction of vaccinia virus complement control protein with human complement proteins: Factor I-MEDIATED degradation of C3b to IC3b(1) inactivates the alternative complement pathway. Molecular Immunology 35 (6-7):371.  
Sahu,A., Morikis,D., Soulika,A.M., Spruce,L., Moore,W.T. and Lambris,J.D. (1998). Species specificity, structural functional analysis and biotransformation studies on Compstatin, a potent complement inhibitor. Molecular Immunology 35 (6-7):371.  
Sarrias,M.R., Zarkadis,I., Sunyer,J.O. and Lambris,J.D. (1998). Cloning of three trout C3 isoforms: Structural, functional, and phylogenetic analysis. Molecular Immunology 35(6-7):370.  
Solvik,U.O., Mollnes,T.E., Fiane,A.E., Vartdal,F., Endresen,M., Thorsby,E. and Lambris,J.D. (1998). Inhibition of complement and xenogeneic endothelial cell activation by Compstatin. Molecular Immunology 35(6-7):372.  
Soulika,A.M., Sahu,A. and Lambris,J.D. (1998). Localization of Compstatin binding site on C3. Molecular Immunology 35(6-7):370.  
Sun,X., Funk,C.D., Deng,C., Sahu,A., Lambris,J.D. and Song,W.C. (1998). Targeted disruption of the murine decay-accelerating factor(DAF) gene: Studies of erythrocytes reveal activity of DAF in regulating both autologous and heterologous complement activation. Molecular Immunology 35 (6-7):372.  
Sunyer,J.O. and Lambris,J.D. (1998). Evolution and diversity of the complement system of poikilothermic vertebrates. Immunological Reviews 166:39-57.  
Sunyer,J.O., Zarkadis,I., Sarrias,M.R., Hansen,J.D., Skiadas,A.P. and Lambris,J.D. (1998). Cloning, structure, and function of two rainbow trout Bf molecules: Both classical and alternative pathway activities require the presence of Bf-2. Molecular Immunology 35(6-7):370.  
Del Rio-Tsonis, K., Tsonis, P. A., Zarkadis, I. K. Tsangas, A. G. Lambris, J. D. (1997). Expression of the third component of complement, C3, in regenerating limb blastema cells of urodeles. Molecular Immunology 34:372.  
Friedman, H. M., Wang, L.Nagashunmugam, T.Lambris, J. D. Pangburn, M. K. Soulika, A. M Wetsel, R. A. Colten, H. R Eisenberg, R. J., Cohen, G. H. Lubinski, J. (1997). JSL-1 glycoprotein gC complement regulatory domains involved in virulence. Molecular Immunology 34:348.  
Gross, P. S. Sunyer, J. O. Lambris, J. D. Smith, L. C. (1997). The sea urchin complement C3 protein: Expression and function. Dev.Comp.Immunol 21(2):150.  
Lambris, J. D., Zarkadis, I. K., and Sunyer, J. O. (1997). Phylogeny and diversity of the third complement component C3. 7th ISDCI Congress.Develop.Comp.Immunol 21:143.  
Mollnes, T. E., Fiane, A. E., Videm, V.Sahu, A.Hovig, T.Mellbye, O. J. Hogasen, K. Spruce, L.Moore, W. T. Lambris, J. D. (1997). Atytenuation of hyperacute xenograft rejection in a porcine-to-human ex vivo model by peptide based C3 inhibitor. Molecular Immunology 34:372.  
Moore, W. T.and Lambris, J. D. (1997). Mass spectrometric analysis of the activation and expression products of the third component of complement(C3). Molecular Immunology 34:373.  
Myones, B. L., Antonov, I. V., Fedorova, L. I. Volgin, A. Y. Lambris, J. D. Peterson, L. H. (1997). Complexes of complement factor H and phospholipids retain cofactor activity for C3 cleavage and are capable of binding human monoclonal antiphospholipid antibodies. Arthritis and Rheumatism 40(9):431.  
Myones, B. L., Antonov, I. V., Fedorova, L. I. Volgin, A. Y. Peterson, L. H. Lambris, J. D. (1997). Complexes of factor H phospholipids retain cofactor activity for C3 Cleavage: relationship to antiphospholipid antibodies. Molecular Immunology 34:373.  
Nilsson, B. Larsson, R., Hong, J.Elgue, G.Nilsson-Ekdahl, K. Sahu, A.and Lambris, J. D. (1997). Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal cilculation. Molecular Immunology 34:371.  
Noorchashm, H., Lieu, Y. K, Wetsel, R. A. Colten, H. R Barker, C. F Soulika, A. M Rostami, S. Y. Lambris, J. D., and Naji, A. B. (1997). B cell tolerance: a C3 depedent process. Molecular Immunology, Noorchashm, H., Lieu, Y. K, Wetsel, R. A. Colten, H. R Barker, C. F Soulika, A. M Rostami, S. Y. Lambris, J. D., and Naji, A. B. (1997). B cell tolerance: a C3 depedent process. Molecular Immunology 34:371.  
Sarrias, M. R., Zarkadis, I. K.Sunyer, J. O. Lambris, J. D. (1997). Cloning of three trout C3 isoforms: structural, functional, and phylogenetic analysis. Molecular Immunology 34:370.  
Solvik, U. O., Mollnes, T. E., Fiane, A. E. Vartdal, A. E. Endresen, M. Thorsby, E. Lambris, J. D. (1997). Inhibition of complement and xenogeneic endothelial cell activation by compstatin. Molecular Immunology 34:372.  
Soulika, A. M, Sahu, A. and Lambris, J. D. (1997). Localization of compstatin binding site on C3. Molecular Immunology 34:370.  
Sunyer, J. O., Zarkadis, I. K., and Lambris, J. D. (1997). Structural and functional characterization of B/C2 complement molecules in teleost fish. Develop.Compar.Immunol 21(2):147.  
Sunyer, J. O., Zarkadis, I. K.Sarrias, M. R. Hansen, R. D. Skiadas, A. P Lambris, J. D. (1997). Clining, structure and function of two rainbow trout Bf molecules: both classical and alternative pathway activities require the presence of Bf-2. Molecular Immunology 34(370).  
Tolnay, M. Lambris, J. D. Tsokos, G. C. (1997). An inducible heterogeneous nuclear ribonucleoprotein which functions as a DNA-binding transactivator. Faseb Journal 11(9):A943.  
Al-Sharif, W., Sunyer, J. O., Lambris, J. D. Smith, L. C. (1997). Characterization of the cDNA encoding a protein homologous to the mammalian complement component C3 which is expressed in sea urchin coelomocytes. 7th ISDCI Congress.Develop.Comp.Immunol 21:147.  
Fisk, B. Dague, B.Seifert, W. E. Lambris, J. D. Papayannopoulos, I. Kudelka, A. Wharton, J. T. Ioannides, C. G. (1996). Ovarian cytotoxic T lymphocytes can recognize common peptides presented by HLA-A2+ tumors. Joint Meeting of the American Society for Biochemistry and Molecular Biology, the American Society for Investigative Pathology andthe American Association of Immunologists, New Orleans, Louisiana, USA 10(6): 2707.  
Friedman, H. M., Wang, L.Burger, R., Lambris, J. D. Eisenberg, R. J. Cohen, G. H. Lubinski, J. (1996). The role of Herpes Simplex Virus type 1 glycoprotein C, a C3b binding protein, in pathogenesis. XVI International Complement Workshop Mol.Immunol 33:63.  
Friedman, H. M., Wang, L.Fishman, N. O., Lambris, J. Eisenberg, R. J. Cohen, G. H. Pangburn, M. K. Lubinski, J. (1996). Immune evasion properties of herpes simplex virus type 1 glycoprotein gC. Journal of Investigative Medicine 44(3):A218.  
Sahu, A. Isaacs, S. N. Lambris, J. D. (1996). Modulation of complement by recombinant vaccinia virus complement control protein. XVI International Complement Workshop Mol.Immunol 33:61.  
Sahu, A. Kay, B. K.and Lambris, J. D. (1996). Inhibition of human complement bya C3 binding peptide isolated from a phage-displayed random peptide library. XVI International Complement Workshop Mol.Immunol 33:61.  
Sunyer, J. O., Zarkadis, I. K.Sahu, A.and Lambris, J. D. (1996). Multiple forms of complement C3 in a tetraploid ad a diploid teleost fish, that differ in binding to complement activators. XVI International Complement Workshop Mol.Immunol 33:61.  
Tolnay, M.and Lambris, J. D. (1996). Purification and characterization of a nuclear protein and binds to a CRE-like motif in the promoter region of the complement receptor-2(CR2) gene. Joint Meeting of the American Society for Biochemistry and Molecular Biology, The american Society for Investigatinve Pathology and the American Association of Immunologists, New Orleans, Louisiana,USA, June 2-6.FASEB Journal 10(6):A1445.  
Kozlowski, L. M., Lambris, J. D., and Levinson, A. I. (1995). Activation of the Complement Cascade by A Putative B-Cell Superantigen. Journal of Allergy and Clinical Immunology 95(1):177.  
Kozlowski, L. M., Lambris, J. D., and Levinson, A. I. (1995). B-Cell Superantigen-Mediated Complement Activation in Mouse and Man. Faseb Journal 9(3):A518.  
Lambris, J. D., Mavroidis, M., and Sunyer, J. O. (1995). Isolation, primary structure and evolution of chicken C3 and evidence for a new member of thea2-M family. FASEB J 9(3):A490.  
Tolnay, M. Lambris, J. D. Smallridge, R. C. Tsokos, G. C. (1995). Transcriptional Control of the Complement Receptor-2 Gene by and Inducible Nuclear-Protein That Binds to A Camp Regulatory Element-Like Motif in the Promoter Region of the Gene. Arthritis and Rheumatism 38(9):27.  
Tolnay, M. Lambris, J. D. Tsokos, G. C. (1995). Regulation of Complement Receptor-2(Cr-2) Expression in Human B-Lymphoblastoid Cell(Blc) Lines. Faseb Journal 9(3):A212.  
Lambris, J. D. and Sunyer, J. O. (1994). Structural and functional analysis of a third isoform of trout third component of complement. 12th European Immunology Meeting, Barcelona, SpainJune  
Lambris, J. D., Lao, Z.Kostavasili, I., and Wang, Y. (1994). Contribution of residues 727-768 of Hu C3 to its interaction with Hu CR1, B, and H. Vth European Meeting on Complement in Human diseases.Les diablerets, Switzerland, September  
Rux, A. H. Lambris, J. D. Wang, Y.Moore, W. T. Abrams, W. R Friedman, H. M. Cohen, G. H. Eisenberg, R. J. (1994). Disulfide bond analysis of trancated HSV gC from a baculovirus expression system. In Abstracts of the 19th Herpesvirus Workshop, Vanvouver, BC  
Tsoukas, C. D., Todd, S. C., and Lambris, J. D. (1994). Epstein-Barr-Virus Induces Proliferation of Human Thymocytes in A Mhc Class Ii-Dependent Fashion. Journal of Cellular Biochemistry 370.  
Hasty, L. A. Brockman, W. W. Lambris, J. D. Lyttle, R. C. (1993). The expression of endometrial complement factor B in patients with and without endometriosis. The Endometrium, Bologna, Italy, September
Hedrick, J. A., Lao, Z.Du, J.Lambris, J. D., and Tsoukas, C. D. (1993). Characterization of a novel EBV/C3 receptor. Mol.Immunol 30:15.  
Kostavasili, I., Peng, C.Hung, S. L., Wang, Y.Friedman, H. M. Eisenberg, R. Cohen, G. H. Lambris, J. D. (1993). Mapping of HSV-1 and HSV-2 gC interaction sites in C3 and modulation of C3 functions. Mol.Immunol 30:25.  
Lambris, J. D. (1993). Phylogenic analysis of C3. American Associaton for Immunologists, Denver, Co.:May 22  
Lambris, J. D., Lao, Z.Mavroidis, M., Pang, J.Pappas, J.Wang, Y.and Manzone, H. (1993). Phylogenic of the third component of complement and conservation of C3-ligand interations. Primodial Immunity Conference Swope Center  
Lambris, J. D., Mavroidis, M., Lao, Z.Pappas, J.Wang, Y.and Suner, O. (1993). Clonning of trout, chicken, and xenopus gilli C3: conservation of functional sites in the C3 from different species. Mol.Immunol 30:27.  
Lao, Z. Wang, Y.and Lambris, J. D. (1993). Interaction of human CR1, CR2 and H with expressed C3 and chimeric C3 modules. Mol.Immunol 30:27.
Hung, S. L. Peng, C.Friedman, H. M. Lambris, J. D. Huemer, H. P. Eisenberg, R. J. Cohen, G. H. (1992). The interaction of HSV gC with the complement system. 17th International Herpesvirus Workshop  
Lambris, J. D., Zhege, L., Wang, Y.Manzone, H. Pang, J.Schwager, J. Mavroidis, M. Alsenz, J. (1992). Evolution of C3-Ligand Interactions. Faseb Journal 6(4):A1453.  
Sinha, S. K. Speiser, C. L. Hedrick, J. A. Escobar, S. Lambris, J. D. Tsoukas, C. D. (1992). Characterization of the Ebv/C3 Receptor on Human Lymphocytes-T. Faseb Journal 6(4): A1451.  
Hasty, L. A. Lessey, B. A. Pruksananonda, S. Lambris, J. D. Lyttle, C. R. (1991). The hormonal regulation of complement components throughout the menstrual cycle. Annual Meeting of the Society for Gynecologic Investigation  
Hedrick, J. A. Watry, D.Speiser, C. O' Donneli, P. Lambris, J. D. Tsoukas, C. D. (1991). Epstein-Barr virus-T lymphocyte interaction via a novel receptor. FASEB J 5(5):A1340.  
Huemer, H. P., Lambris, J. D., Lacher, C.Enquist, L. Babiuk, L.Eisenberg, R. J. Cohen, G. H. Friedman, H. M. (1991). Binding of complement component C3 to HSV-1 gC and gc homologous of PRV and BHV-1. 16th International Herpesvirus Workshop, Asilomar, CA  
Pruksananonda, S., Caltalbiano, S.Lambris, J. D. Lyttle, C. R. (1991). Hormonal regulation of rat uterine C3 and factor B. Complement and Inflammation 8:213.  
Alsenz, J. Becherer, D., Esparza, I. Daoudaki, M. Avila, D.Oppermann, S. Lambris, J. D. (1989). Structure and Function Analysis of C3 from Different Species. Complement and Inflammation 6:307.  
Becherer, J. D., Alsenz, J. A., Hack, C. E. Drakopoulou, E. Lambris, J. D. (1989). Identification of common binding domains in C3b for members of the complement family of C3b-binding proteins. Complement and Inflammation 6:313.  
Esparza, I. Vilbois, F., Becherer, J. D. Lambris, J. D. (1989). Multiple sites of interaction in C3 for CR2/EBV-receptor: functional implications. Complement and Inflammation 6:334.  
Huemer, H. P., Burger, R., Garred, P.Cohen, G.Eisenberg, R. Friedman, H. Esparza.I.Dierich, M. P. Lambris, J. D. (1989). The interaction sites in C3b for HSV-1 gC and factor H are related. Complement and Inflammation 6:348.  
Myones, B. L., Avila, D. , Lachmann, P. J. Lambris, J. D. (1989). Lacalization of the epitopes recognized by anti-C3dg(clone 9) monoclonal antibody using synthetic peptides. Complement and Inflammation 6:373.  
Nilsson, B. Grossberger, D. Nilsson-Ekdahl, K. Riegert, P. Becherer, J. D. Nilsson, U. R. Lambris, J. D. (1989). Localization of neoantigenic epitopes in bound C3 fragments. Complement and Inflammation 6:181.  
Nilsson-Ekdahl, K., Nilsson, B., Becherer, J. D. Nilsson, U. R. Lambris, J. D. (1989). Further studies on the degradation of complement factor C3 by factor I. Inhibition of factor I with DFP. Complement and Inflammation 6:332.  
Tsokos, G. Lambris, J. D. Finkelman, F. D. Anastasiou, E. D. June, C. H. (1989). Monovalent ligants of complement receptor 2 inhibit while polyvalent ligants enhance anti-immunoglobulin induced human B cell intracytoplasmic free calcium concentration. Complement and Inflammation 6:407.  
Wörner, I. Burger, R.and Lambris, J. D. (1989). Localization and functional characterization of epitopes on alpha and beta chains of C3. Complement and Inflammation 6:416.  
Alsenz, J.and Lambris, J. D. (1988). Modulation of factor H(H) functional activities by monoclonal antibodies(MoAbs) to H. Complement 5:202.  
Bogen, B. Weiss, S.and Lambris, J. D . (1988). B lymphoma cells process and present their surface Ig V-regions to MHC-restricted T cells. Ninth European Immunology Meeting, Roma  
Bogen, B.and Lambris, J. D. (1988). An eleven aminoacid long peptide activates idiotope-specific, I-E d restricted T cell clones. International Immunology Meeting, Berlin 15:4.  
Grossberger, D., Riegert, P., Becherer, J. D. Nilsson, B. Nilssonekdahl, K. Nilsson, U. R., and Lambris, J. D. (1988). Monoclonal Anti-C3 Antibodies Specific for Either Bound Or Fluid Phase C-3 - Mapping of Their Antigenic Sites in C-3 by the Use of Expression Minilibrary. Faseb Journal 2(6):A1643.  
Nilsson, B. Nilsson Ekdahl, K. Avila, D.Nilsson, U. R. Lambris, J. D. (1988). Monoclonal anti-C3 antibodies specific for bound iC3b: Mapping of the recognized epitopes on C3 by synthetic peptides. Complement 5:206.  
Huemer,H.P., Broker,M., Lambris,J. and Dierich,M.P. (1988). Hsv Type-1 Interaction with Human Complement-Binding Specifity of A Viral Pathogenicity Factor. Immunobiology 178(1-2):63.  
Becherer, D.and Lambris, J. D. (1987). Localization of C3b receptor binding domain in C3. Complement 4:132.  
Becherer, J. D., Daoudaki, M. E., and Lambris, J. D. (1987). Conservation of the C-3 Ligand-Binding Sites Within Different Species. Federation Proceedings 46(3):771.  
Daoudaki, M. E. and Lambris, J. D. (1987). The properdin binding site in C3 as delineated by synthetic peptides. Complement 4:146.  
Daoudaki, M. E., Becherer, J. D., and Lambris, J. D. (1987). Localization of the P and C5 binding sites on the third component of complement. Fed.Proc 46:1024.  
Lambris, J. D., Avila, D., and Becherer, J. D. (1987). Interaction of factor H with C3 :Involvement of two C3 sites in the H cofactor activity. Complement 4:183.  
Lambris, J. D., Becherer, J. D.Avila, D.and Müller-Eberhard, H. J. (1986). Localization of the factor H binding site on the third component of complement. Immunobiology 173:493.  
Fishelson, Z., Lambris, J. D., and Müller-Eberhard, H. J. (1985). Modulation of complement C3bBb activity and stability by monoclonal antibodies to Bb. Complement 2:25.  
Hirani, S. Lambris, J. D. Mullereberhard, H. J. (1985). Analysis of the Carbohydrate Moieties of the 3Rd Component of Human-Complement. Federation Proceedings 44(4):989.  
Lambris, J. D., Becherer, D., and Müller-Eberhard, H. J. (1985). Localization of the factor H binding site on complement C3. Complement 2:48.  
Lambris, J. D., Ganu, V. S., Hirani, S.and Mullereberhard, H. J. (1985). Mapping of the C3D Receptor(Cr2)-Binding Site and A Neoantigenic Site in the C3D Domain of the 3Rd Component of Complement. Proceedings of the National Academy of Sciences of the United States of America 82(12):4235.  
Lambris, J. D., Hirani, S., Ganu, V. S. Becherer, D. Müller-Eberhard, H. J. (1985). Localization of the complement C3d receptor binding site and monoclonal antibody 130 antigenic site on complement C3. Fed.Proc 44:1531.  
Tsokos, G. C. and Lambris, J. D. (1985). Modulation of Cyto-Toxic Responses by Complement - C3C3B and C3D Fragments Enhance Allogeneic Cell-Mediated Lympholysis. Federation Proceedings 44(6):1877.  
Aguado, M. T., Lambris, J. D., Tamerius, J. D. Dixon, F. J. Theofilopoulos, A. N. (1984). Use of anti-C3 monoclonal antibodies to detect C3-bearing immune complexes and complement activation. Fed.Proc 43:1614.  
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P. (1984). Structure-Function Relationship of Factor-H Investigated by Enzymatic Cleavages and Monoclonal Anti-H Antibodies. Immunobiology 168(1-2):97.  
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P. (1984). The C3b binding site and the cofactor activity is localized in the 38Kd trypsin fragment of factor H. Fed.Proc 43:1447.  
Lambris, J. D., Hirani, S., Ganu, V.and Müller-Eberhard, H. J. (1984). Molecular aspects of the complement C3 interaction with conglutinin complement receptor CR3 and complement receptor CR2. Complement 1 :165.  
Tsokos, G. C., Inghirami, G., Balow, J. E. Tsoukas, C. D. Lambris, J. D. (1984). Regulation of immunoglobulin secretion by human B cells in vitro by factor H. Fed.Proc 43 :1763.  
Alsenz, J. Lambris, J. D. Schulz, T. F. Dierich, M. P. (1983). Localization of Functionally Relevant Sites in Factor-H. Immunobiology 165(3-4):236.  
Alsenz, J. Lambris, J. Schulz, T. F. Dierich, M. P. (1983). Localization of the C3B-Binding Site in Factor-H. Immunobiology 164(3-4):204.  
Schulz, T. F., Rieber, P., Lambris, J. Riethmuller, G. Dierich, M. P. (1983). Antigenic Relationship Between the Membrane-Receptor for Factor-H, the Alpha-Chain of C-3, and A Leukocyte Surface-Antigen Defined by Monoclonal Antibody-M522. Immunobiology 164(3-4):295.  
Schulz, T. F., Scharfenberger, H.Rieber, P.Lambris, J. D. Riethmuller, G. Dierich, M. P. (1983). The Leukocyte Surface Antigen-M522, Antigenically Related to the H-Receptor and the Alpha-Chain of C-3, Is Involved in the Activation of Human-Monocytes and Neutrophils. Immunobiology 165(3-4): 356.  
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P. (1983). Involvement of Membrane-Associated Factor-H in the C3B-Receptor Function of Human Lymphocytes-B Investigated with Monoclonal-Antibodies Against Human Factor-H. Immunobiology 164(3-4):296.  
Scheiner,O., Schulz,T., Lambris,J., Schmid,H.U., Alsenz,J. and Dierich,M.P. (1983). Role of Membrane-Associated Factor-H in the Binding of C3B-Coated Erythrocytes to Lymphoid-Cells. Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene Series A-Medical Microbiology Infectious Diseases Virology Parasitology 253(4):439.  
Lambris, J. D., Cohen, P. L., Dobson, N. J. Wheeler, P. W. Papamichail, M. Ross, G. D. (1982). Effect of Antibodies to Cr-2(C3D Receptors) on Lymphocyte-Activation. Clinical Research 30(2):A514.  
Lambris, J. D., Scheiner, O., Schulz, T. F. Dierich, M. P. (1982). Coupling of C3B to Erythrocytes by Disulfide Bond Formation - Preparation of Stable and Sensitive E-C3B for Hemolytic and Complement Receptor Assays. Immunobiology 162(4-5): 383.  
Lambris, J. D., Schulz, T. F., Schreiner, O. Dierich, M. P. (1982). Preparation of complement C3b coated erythrocytes for hemolytic and complement receptor assays by coupling complement C3b to activated thiol erythrocytes. Immunobiology 163:203.  
Macrae, E. K., Pryzwansky, K. B.Schwab, J. H. Lambris, J. D. (1982). Aggregation of Human-Leukocytes and Erythrocytes After Stimulation with Serum-Opsonized Streptococcal Cell-Wall. Journal of Cell Biology 95(2):A13.  
Ross, G. D.and Lambris, J. D. (1982). Identification of 3 Forms of Ic3B That Have Distinct Structures and Receptor-Binding Site Properties. Molecular Immunology 19(11):1399.  
Schreiner, O., Schulz, T., Lambris, J. Schmid, H. U. Alsenz, J.and Dierich, M. P. (1982). The Role of Membrane-Associated Factor-H for the Binding of C3B-Coated Erythrocytes to Lymphoid-Cells. Immunobiology 162(4-5):415.  
Schulz, T. F., Alsenz, J., Scheiner, O. Lambris, J. D. Dierich, M. P. (1982). Use of monoclonal antibodies against factor H to investigate the role of factor H in complement C3b dependent rosette formation. Immunobiology 162:421.  
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P. (1982). Use of monoclonal antibodies against factor H to demonstrate the presence of factor H in lymphocyte membranes and to investigate its role in immunoadherence. First International Workshop on Human Differentiation AntigensImmunobiology, Paris  
Pryzwansky,K.B., Lambris,J.D., Schwab,J.H. and Macrae,E.K. (1982). Capping of Complement Receptors on Human-Neutrophils Induced by Opsonized Group A Streptococcal Cell-Walls. Journal of Cell Biology 95(2):A437.  
Schulz, T. F., Scheiner, O., Alsenz, J.Lambris, J. D. Dierich, M. P. (1982). Involvement of membrane associated factor H in complement C3b dependent rosette formation demonstrated by mono clonal antibodies against human factor H. Immunobiology 163:207.  
Dobson, N. J., Lambris, J. D., Bleau, S. A. Ross, G. D. (1981). Role of Human Neutrophil Complement Receptors and Beta-1H in the Release of Superoxide Anion. Federation Proceedings 40(3):1014.  
Hutt Fletcher, L. M.Fowler, E., Simmons, J. Feighay, R. Lambris, J. D. Ross, G. D. (1981). Characterization of Raji cell extract that binds the Epstein-Barr virus. Int.Workshop on Herpes Virus  
Lambris, J. D., Dobson, N. J., and Ross, G. D. (1981). Isolation of Lymphocyte Membrane Complement Receptor Type-2 (the C3D Receptor) and Preparation of Receptor-Specific Antibody. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences 78(3):1828.  
Newman, S. L., Dobson, N. J., Lambris, J. D., Ross, G. D. Henson, P. M. (1981). Specificity and Function of Human Macrophage Complement Receptors for Different Fragments of C-3. Federation Proceedings, 40(3):1017.  
Lambris,J.D., Dobson,N.J., Dozier,M. and Ross,G.D. (1981). Antibody to the Idiotype of Anti-Beta-1H Has Specificity for Beta-1H Lymphocyte-B Membrane Beta-1H Receptors and C3B. Federation Proceedings 40 (3):1013.  
Hutt Fletcher, L. M.,Fowler, E., Feighny, R. J. Sullivan, B. Lambris, J. D. Ross, G. D. (1980). Epstein-Barr and C3d are bound by different components of cell membrane. Fifth Herpes Virus Workshop. Cold Spring Harbor  
Ross, G. D. Lambris, J. D. Dobson, N. J. (1980). B lymphocyte response to complement activators: release of endogenous C3b inactivator(C3bINA) following exposure to C5 convertase. Abstracts 4th Int.Cong.Immunol.,Paris  
Huber-Lang, M., Sarma, V., Younkin, E. M. McGuire, S. R. Lu, K. T.Neff, T.Guo, R. F.Gebhard, F. Lambris, J. D. Ward, P. A. International Immunopharmacology. Protective effects by C5aR antagonist(C5aRa) during experimental sepsis 2:1244.